137 related articles for article (PubMed ID: 34877846)
1. Targeted phototherapy with excimer light is not efficacious in the management of residual vitiligo patches following whole-body narrowband ultraviolet B light therapy: Results of a retrospective case series.
Yadav D; Khandpur S; Bhari N
Indian J Dermatol Venereol Leprol; 2022; 88(2):249-251. PubMed ID: 34877846
[No Abstract] [Full Text] [Related]
2. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
Poolsuwan P; Churee C; Pattamadilok B
Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
[TBL] [Abstract][Full Text] [Related]
4. Twenty-year follow-up using a postal survey of childhood vitiligo treated with narrowband ultraviolet B phototherapy.
Lommerts JE; Njoo MD; de Rie MA; Wolkerstorfer A; Bekkenk MW
Br J Dermatol; 2017 Sep; 177(3):e60-e61. PubMed ID: 28117877
[No Abstract] [Full Text] [Related]
5. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
6. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
7. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.
Mohammad TF; Al-Jamal M; Hamzavi IH; Harris JE; Leone G; Cabrera R; Lim HW; Pandya AG; Esmat SM
J Am Acad Dermatol; 2017 May; 76(5):879-888. PubMed ID: 28216034
[TBL] [Abstract][Full Text] [Related]
8. Are very high cumulative doses of narrowband UVB safe in vitiligo?
Momen S; Sarkany R
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):220-221. PubMed ID: 28370729
[No Abstract] [Full Text] [Related]
9. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.
Nicolaidou E; Antoniou C; Stratigos A; Katsambas AD
J Am Acad Dermatol; 2009 Mar; 60(3):470-7. PubMed ID: 19157641
[TBL] [Abstract][Full Text] [Related]
10. Narrowband ultraviolet B phototherapy in pediatric vitiligo: A retrospective study.
Garza-Mayers AC; Paquette GM; Harris JE; Wiss K
J Am Acad Dermatol; 2023 Jul; 89(1):135-136. PubMed ID: 36796727
[No Abstract] [Full Text] [Related]
11. Efficacy and Safety of Targeted High-Intensity Medium-Band (304-312 nm) Ultraviolet B Light in Pediatric Vitiligo.
Dong DK; Pan ZY; Zhang J; Lu XF; Jin C; Tao SQ; Yang LJ
Pediatr Dermatol; 2017 May; 34(3):266-270. PubMed ID: 28318054
[TBL] [Abstract][Full Text] [Related]
12. Targeted ultraviolet B phototherapy in vitiligo: A comparison between once-weekly and twice-weekly treatment regimens.
Majid I; Imran S
Indian J Dermatol Venereol Leprol; 2015; 81(6):600-5. PubMed ID: 26515839
[TBL] [Abstract][Full Text] [Related]
13. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren's syndrome.
Tanioka M; Takahashi K; Miyachi YI
Clin Exp Dermatol; 2009 Apr; 34(3):418-20. PubMed ID: 19120387
[No Abstract] [Full Text] [Related]
14. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study.
Hong SB; Park HH; Lee MH
J Korean Med Sci; 2005 Apr; 20(2):273-8. PubMed ID: 15832000
[TBL] [Abstract][Full Text] [Related]
15. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
[TBL] [Abstract][Full Text] [Related]
17. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study.
Wind BS; Kroon MW; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Meesters AA; Bos JD; Wolkerstorfer A
Br J Dermatol; 2010 May; 162(5):1142-4. PubMed ID: 20199553
[No Abstract] [Full Text] [Related]
18. Phototherapy and Combination Therapies for Vitiligo.
Esmat S; Hegazy RA; Shalaby S; Hu SC; Lan CE
Dermatol Clin; 2017 Apr; 35(2):171-192. PubMed ID: 28317527
[TBL] [Abstract][Full Text] [Related]
19. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review.
Alhowaish AK; Dietrich N; Onder M; Fritz K
Lasers Med Sci; 2013 May; 28(3):1035-41. PubMed ID: 22892613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
